nodes	percent_of_prediction	percent_of_DWPC	metapath
Aluminium—TF—urine—urinary bladder cancer	0.206	0.291	CbGeAlD
Aluminium—TF—prostate gland—urinary bladder cancer	0.0741	0.105	CbGeAlD
Aluminium—TF—epithelium—urinary bladder cancer	0.0544	0.0768	CbGeAlD
Aluminium—TF—Iron metabolism in placenta—TFRC—urinary bladder cancer	0.0531	0.183	CbGpPWpGaD
Aluminium—TF—renal system—urinary bladder cancer	0.0505	0.0712	CbGeAlD
Aluminium—TF—female reproductive system—urinary bladder cancer	0.0404	0.0571	CbGeAlD
Aluminium—ATP1A1—prostate gland—urinary bladder cancer	0.0371	0.0524	CbGeAlD
Aluminium—TF—vagina—urinary bladder cancer	0.0366	0.0516	CbGeAlD
Aluminium—ATP1A1—seminal vesicle—urinary bladder cancer	0.0314	0.0443	CbGeAlD
Aluminium—ATP1A1—epithelium—urinary bladder cancer	0.0273	0.0385	CbGeAlD
Aluminium—ATP1A1—smooth muscle tissue—urinary bladder cancer	0.0263	0.0371	CbGeAlD
Aluminium—TF—Transferrin endocytosis and recycling—TFRC—urinary bladder cancer	0.0262	0.0901	CbGpPWpGaD
Aluminium—ATP1A1—renal system—urinary bladder cancer	0.0253	0.0357	CbGeAlD
Aluminium—ATP1A1—urethra—urinary bladder cancer	0.0249	0.0351	CbGeAlD
Aluminium—TF—lymph node—urinary bladder cancer	0.0237	0.0334	CbGeAlD
Aluminium—ATP1A1—Preimplantation Embryo—AQP3—urinary bladder cancer	0.0229	0.0788	CbGpPWpGaD
Aluminium—ATP1A1—Preimplantation Embryo—CDX2—urinary bladder cancer	0.022	0.0755	CbGpPWpGaD
Aluminium—ATP1A1—female reproductive system—urinary bladder cancer	0.0203	0.0286	CbGeAlD
Aluminium—TF—Iron uptake and transport—TFRC—urinary bladder cancer	0.0191	0.0658	CbGpPWpGaD
Aluminium—ATP1A1—vagina—urinary bladder cancer	0.0183	0.0259	CbGeAlD
Aluminium—TF—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	0.0136	0.0467	CbGpPWpGaD
Aluminium—ATP1A1—lymph node—urinary bladder cancer	0.0119	0.0167	CbGeAlD
Aluminium—ATP1A1—Ion channel transport—TRPV1—urinary bladder cancer	0.00822	0.0282	CbGpPWpGaD
Aluminium—TF—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.00814	0.028	CbGpPWpGaD
Aluminium—TF—Differentiation Pathway—IGF1—urinary bladder cancer	0.0081	0.0278	CbGpPWpGaD
Aluminium—TF—EPHB forward signaling—SRC—urinary bladder cancer	0.00642	0.022	CbGpPWpGaD
Aluminium—TF—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.00636	0.0218	CbGpPWpGaD
Aluminium—TF—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.00601	0.0207	CbGpPWpGaD
Aluminium—ATP1A1—Preimplantation Embryo—CDH1—urinary bladder cancer	0.00587	0.0201	CbGpPWpGaD
Aluminium—TF—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00579	0.0199	CbGpPWpGaD
Aluminium—TF—Platelet degranulation—IGF1—urinary bladder cancer	0.00538	0.0185	CbGpPWpGaD
Aluminium—TF—EPHB forward signaling—KRAS—urinary bladder cancer	0.00531	0.0182	CbGpPWpGaD
Aluminium—TF—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.00513	0.0176	CbGpPWpGaD
Aluminium—ATP1A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00485	0.0167	CbGpPWpGaD
Aluminium—TF—EPHB forward signaling—HRAS—urinary bladder cancer	0.00452	0.0155	CbGpPWpGaD
Aluminium—TF—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.00433	0.0149	CbGpPWpGaD
Aluminium—TF—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00419	0.0144	CbGpPWpGaD
Aluminium—ATP1A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00351	0.0121	CbGpPWpGaD
Aluminium—TF—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00341	0.0117	CbGpPWpGaD
Aluminium—TF—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.0032	0.011	CbGpPWpGaD
Aluminium—ATP1A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00286	0.00983	CbGpPWpGaD
Aluminium—TF—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.00254	0.00872	CbGpPWpGaD
Aluminium—TF—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	0.00239	0.0082	CbGpPWpGaD
Aluminium—TF—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00231	0.00792	CbGpPWpGaD
Aluminium—TF—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	0.00219	0.00752	CbGpPWpGaD
Aluminium—TF—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.00218	0.00748	CbGpPWpGaD
Aluminium—TF—Hemostasis—IFNA2—urinary bladder cancer	0.00213	0.00732	CbGpPWpGaD
Aluminium—ATP1A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00193	0.00664	CbGpPWpGaD
Aluminium—TF—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	0.00184	0.00631	CbGpPWpGaD
Aluminium—TF—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.00177	0.00607	CbGpPWpGaD
Aluminium—TF—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	0.0016	0.0055	CbGpPWpGaD
Aluminium—TF—Hemostasis—PLAU—urinary bladder cancer	0.00151	0.00519	CbGpPWpGaD
Aluminium—TF—Hemostasis—CREBBP—urinary bladder cancer	0.00125	0.00428	CbGpPWpGaD
Aluminium—TF—Hemostasis—IGF1—urinary bladder cancer	0.00123	0.00423	CbGpPWpGaD
Aluminium—TF—Hemostasis—RHOA—urinary bladder cancer	0.00113	0.00387	CbGpPWpGaD
Aluminium—TF—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.00108	0.00371	CbGpPWpGaD
Aluminium—TF—Hemostasis—IL2—urinary bladder cancer	0.000946	0.00325	CbGpPWpGaD
Aluminium—ATP1A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000904	0.00311	CbGpPWpGaD
Aluminium—TF—Hemostasis—EP300—urinary bladder cancer	0.000849	0.00292	CbGpPWpGaD
Aluminium—TF—Hemostasis—SRC—urinary bladder cancer	0.000826	0.00284	CbGpPWpGaD
Aluminium—TF—Hemostasis—KRAS—urinary bladder cancer	0.000684	0.00235	CbGpPWpGaD
Aluminium—TF—Hemostasis—TP53—urinary bladder cancer	0.000608	0.00209	CbGpPWpGaD
Aluminium—TF—Hemostasis—HRAS—urinary bladder cancer	0.000581	0.002	CbGpPWpGaD
